What if we could target ageing in Parkinson’s disease?
Mickael Decressac’s lab at the Telethon Institute of Genetics and Medicine (TIGEM) aims to identify potential therapeutic targets of Parkinson’s, validate them in relevant and complementary models of the condition, and finally, design clinically relevant strategies in order to bring them to the bedside.
In 2012, he developed a viral vector-based model of Parkinson’s, which is widely used for studying the pathological mechanisms and testing protective therapies. Notably, he used this model to uncover novel mechanisms underlying the response of affected neurons to neurotrophic factors and contributed to understanding how the cellular clearance pathways are involved in the disease process. His current research is focused on understanding and modeling Parkinson’s as well as developing new therapeutic approaches using translational approaches.
15 November 2016, 16:00 (Tuesday, 6th week, Michaelmas 2016)
Sherrington Building, off Parks Road OX1 3PT
Sherrington Library, please note doors are locked at 4pm
Mickael Decressac (Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy)
Department of Physiology, Anatomy and Genetics (DPAG)
Melanie Witt (University of Oxford, Department of Earth Sciences, Department of Physiology Anatomy and Genetics)
Organiser contact email address:
OPDC Seminar Series (DPAG)
Members of the University only